florfenicol has been researched along with cephalosporin c in 18 studies
| Studies (florfenicol) | Trials (florfenicol) | Recent Studies (post-2010) (florfenicol) | Studies (cephalosporin c) | Trials (cephalosporin c) | Recent Studies (post-2010) (cephalosporin c) |
|---|---|---|---|---|---|
| 628 | 70 | 420 | 20,476 | 2,093 | 4,152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Hamel, U; Philipp, H; Quirke, JF; Schmidt, H | 1 |
| Carter, JN; Confer, AW; Gill, DR; Krehbiel, CR; Meredith, GL; Montelongo, M; Payton, ME | 1 |
| Chan, JP; Chang, CC; Chang, YC; Chen, TH; Hsieh, YM; Hsuan, SL; Lai, TC; Lin, WH; Wang, YC; Yeh, KS | 1 |
| Cloeckaert, A; Doublet, B; Jouy, E; Kobisch, M; Lazizzera, C; Madec, JY; Meunier, D | 1 |
| Berg, J; Booker, CW; Borciaga-Robles, LO; Fenton, RK; Hannon, SJ; Jim, GK; Perrett, T; Pollock, CM; Schunicht, OC; Vogstad, AR; Wildman, BK | 1 |
| Henwood, BM; Jayarao, BM; Kariyawasam, S; Karunathilake, KE; Kunze, ME; Soehnlen, MK; Wolfgang, DR | 1 |
| Chrzastek, K; Madej, JP; Mytnik, E; Wieliczko, A | 1 |
| Blondeau, BJ; Blondeau, JM; Blondeau, LD; Borsos, S; Hesje, CE | 1 |
| Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G | 1 |
| Chen, WT; Pham, M; Schideman, L; Sharma, BK; Zhang, Y | 1 |
| Govendir, M; Martin, PA; Woerde, DJ | 1 |
| Alina, W; Klaudia, C | 1 |
| Kaspar, H; Kehrenberg, C; Klein, G; Kopp, PA; Meemken, D; Prüller, S; Rensch, U | 1 |
| Call, DR; Liu, J; Orfe, L; Subbiah, M; Zhao, Z | 1 |
| Foster, DM; Martin, LG; Papich, MG | 1 |
| Nariya, H; Shimamoto, T; Soliman, AM | 1 |
| Blondeau, JM; Fitch, SD | 1 |
3 trial(s) available for florfenicol and cephalosporin c
| Article | Year |
|---|---|
[Treatment of acute respiratory tract diseases in cattle with Bisolvon in combination with either enrofloxacin, cefquinome, ceftiofur or florfenicol].
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Bromhexine; Cattle; Cattle Diseases; Cephalosporins; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Injections; Quinolones; Respiratory Tract Infections; Thiamphenicol | 1998 |
Efficacy of a florfenicol-flunixin meglumine combination product versus tulathromycin or ceftiofur crystalline free acid for the treatment of undifferentiated fever in feedlot calves.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Cephalosporins; Clonixin; Disaccharides; Drug Combinations; Fever; Heterocyclic Compounds; Housing, Animal; Thiamphenicol | 2009 |
The influence of antibiotics on B-cell number, percentage, and distribution in the bursa of Fabricius of newly hatched chicks.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; B-Lymphocytes; Bursa of Fabricius; Cephalosporins; Chickens; Enrofloxacin; Fluoroquinolones; Male; Thiamphenicol | 2011 |
15 other study(ies) available for florfenicol and cephalosporin c
| Article | Year |
|---|---|
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Relationship of vitamin E supplementation and antimicrobial treatment with acute-phase protein responses in cattle affected by naturally acquired respiratory tract disease.
Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Female; Macrolides; Random Allocation; Respiratory Tract Diseases; Thiamphenicol; Tylosin; Vitamin E | 2002 |
Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates.
Topics: Actinobacillus pleuropneumoniae; Anti-Bacterial Agents; Arginine; Cephalosporins; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Serotyping; Taiwan; Thiamphenicol | 2010 |
Plasmid-borne florfenicol and ceftiofur resistance encoded by the floR and blaCMY-2 genes in Escherichia coli isolates from diseased cattle in France.
Topics: Animals; beta-Lactamases; Cattle; Cattle Diseases; Cephalosporins; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Thiamphenicol | 2010 |
In vitro antimicrobial inhibition of Mycoplasma bovis isolates submitted to the Pennsylvania Animal Diagnostic Laboratory using flow cytometry and a broth microdilution method.
Topics: Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Cephalosporins; Enrofloxacin; Erythromycin; Flow Cytometry; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma bovis; Mycoplasma Infections; Oxytetracycline; Spectinomycin; Tetracycline; Thiamphenicol | 2011 |
Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Thiamphenicol; Tylosin; United States | 2012 |
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol | 2015 |
Effects of hydrothermal liquefaction on the fate of bioactive contaminants in manure and algal feedstocks.
Topics: Animals; Azotobacter; Benzhydryl Compounds; Biotechnology; Carbon Radioisotopes; Cephalosporins; Chromatography, High Pressure Liquid; DNA; Electroporation; Escherichia coli; Estrone; Manure; Phenols; Plasmids; Spirulina; Sus scrofa; Temperature; Thiamphenicol; Transformation, Genetic; Water; Water Pollutants, Chemical | 2013 |
Susceptibility of rapidly growing mycobacteria isolated from Australian cats to ivermectin, moxidectin, ceftiofur and florfenicol.
Topics: Animals; Anti-Bacterial Agents; Australia; Cat Diseases; Cats; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Ivermectin; Macrolides; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium fortuitum; Mycobacterium Infections; Thiamphenicol | 2015 |
The influence of enrofloxacin, florfenicol, ceftiofur and E. coli LPS interaction on T and B cells subset in chicks.
Topics: Animals; Anti-Bacterial Agents; B-Lymphocytes; Cephalosporins; Enrofloxacin; Escherichia coli; Fluoroquinolones; Lipopolysaccharides; Male; Spleen; T-Lymphocyte Subsets; Thiamphenicol; Thymus Gland | 2015 |
Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bordetella bronchiseptica; Cephalosporins; Microbial Sensitivity Tests; Pets; Swine; Thiamphenicol | 2015 |
Soil-borne reservoirs of antibiotic-resistant bacteria are established following therapeutic treatment of dairy calves.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Drug Residues; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Oxytetracycline; Soil; Soil Microbiology; Thiamphenicol | 2016 |
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cattle; Cephalosporins; Cross-Over Studies; Disaccharides; Enrofloxacin; Epithelial Cells; Extracellular Fluid; Fluoroquinolones; Heterocyclic Compounds; Lung; Male; Mannheimia haemolytica; Microbial Sensitivity Tests; Respiratory Mucosa; Thiamphenicol; Veterinary Drugs | 2016 |
Emergence of
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Chromosome Mapping; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genomic Islands; Humans; Integrons; Male; Morganella morganii; Proteus Infections; Providencia; Salmonella typhimurium; Thiamphenicol | 2019 |
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Topics: Actinobacillus pleuropneumoniae; Animal Husbandry; Animals; Anti-Bacterial Agents; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Heterocyclic Compounds; Microbial Sensitivity Tests; Pasteurella multocida; Streptococcus suis; Swine; Swine Diseases; Thiamphenicol; Tylosin | 2019 |